
Colgate-Palmolive Company CL
$ 93.0
-1.08%
Colgate-Palmolive Company ROA Ratio | CL
Annual ROA Ratio Colgate-Palmolive Company
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 | 2009 | 2008 | 2007 | 2006 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 13.06 | 18.0 | 14.03 | 11.35 | 14.4 | 16.93 | 15.74 | 19.74 | 15.97 | 20.14 | 11.57 | 16.2 | 16.15 | 18.46 | 19.11 | 19.72 | 20.58 | 19.61 | - | - |
Annual performance
Select metrics to display
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 20.58 | 11.35 | 16.71 |
Quarterly ROA Ratio Colgate-Palmolive Company
| 2026-Q2 | 2026-Q1 | 2025-Q3 | 2025-Q2 | 2025-Q1 | 2024-Q3 | 2024-Q2 | 2024-Q1 | 2023-Q3 | 2023-Q2 | 2023-Q1 | 2022-Q4 | 2022-Q3 | 2022-Q2 | 2022-Q1 | 2021-Q4 | 2021-Q3 | 2021-Q2 | 2021-Q1 | 2020-Q4 | 2020-Q3 | 2020-Q2 | 2020-Q1 | 2019-Q4 | 2019-Q3 | 2019-Q2 | 2019-Q1 | 2018-Q4 | 2018-Q3 | 2018-Q2 | 2018-Q1 | 2017-Q4 | 2017-Q3 | 2017-Q2 | 2017-Q1 | 2016-Q4 | 2016-Q3 | 2016-Q2 | 2016-Q1 | 2015-Q4 | 2015-Q3 | 2015-Q2 | 2015-Q1 | 2014-Q4 | 2014-Q3 | 2014-Q2 | 2014-Q1 | 2013-Q4 | 2013-Q3 | 2013-Q2 | 2013-Q1 | 2012-Q4 | 2012-Q3 | 2012-Q2 | 2012-Q1 | 2011-Q4 | 2011-Q3 | 2011-Q2 | 2011-Q1 | 2010-Q3 | 2010-Q2 | 2010-Q1 | 2009-Q3 | 2009-Q2 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 16.47 | 16.48 | 16.99 | 17.23 | 17.1 | 17.36 | 16.06 | 13.93 | 13.6 | 12.74 | 13.64 | 11.34 | 15.74 | 11.94 | 16.25 | 12.7 | 16.76 | 17.15 | 16.75 | 16.93 | 17.14 | 16.6 | 16.51 | 15.74 | 16.45 | 16.91 | 18.25 | 19.74 | 17.3 | 17.79 | 16.68 | 15.97 | 18.42 | 19.42 | 20.24 | 20.14 | 11.3 | 11.59 | 11.45 | 11.6 | 20.11 | 18.05 | 17.86 | 16.2 | 15.56 | 16.26 | 15.69 | 16.12 | 16.55 | 16.71 | 17.34 | 18.46 | 18.63 | 18.8 | 19.01 | 19.11 | 19.9 | 20.55 | 18.96 | 19.76 | 19.56 | 3.3 | 5.33 | 5.23 |
Quarterly performance
Select metrics to display
All numbers in USD currency
Indicator range from quarterly reporting
| Maximum | Minimum | Average |
|---|---|---|
| 20.55 | 3.3 | 16.08 |
ROA Ratio of other stocks in the Household products industry
| Issuer | ROA Ratio | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
|
The Clorox Company
CLX
|
14.57 | $ 86.84 | 0.51 % | $ 10.7 B | ||
|
Spectrum Brands Holdings
SPB
|
2.96 | $ 80.14 | 0.35 % | $ 2.06 B | ||
|
Coty
COTY
|
-5.93 | $ 3.21 | -0.77 % | $ 2.82 B | ||
|
United-Guardian
UG
|
16.06 | $ 6.62 | -0.75 % | $ 30.4 M | ||
|
Revlon
REV
|
-27.07 | - | -4.41 % | $ 212 M | ||
|
Acme United Corporation
ACU
|
5.96 | $ 63.8 | 0.5 % | $ 242 M | ||
|
The Estée Lauder Companies
EL
|
0.92 | $ 108.91 | 0.22 % | $ 39.5 B | ||
|
Helen of Troy Limited
HELE
|
-42.49 | $ 28.26 | 0.68 % | $ 650 M | ||
|
Church & Dwight Co.
CHD
|
8.27 | $ 105.15 | -0.04 % | $ 25.5 B | ||
|
Dogness (International) Corporation
DOGZ
|
-29.35 | $ 0.7 | -5.38 % | $ 12.5 M | ||
|
Hims & Hers Health
HIMS
|
5.96 | $ 27.6 | -0.4 % | $ 6.21 B | ||
|
Kimberly-Clark Corporation
KMB
|
2.92 | $ 109.62 | -0.48 % | $ 36.4 B | ||
|
Natura &Co Holding S.A.
NTCO
|
6.96 | - | - | $ 9.02 B | - | |
|
USANA Health Sciences
USNA
|
1.45 | $ 14.08 | 0.82 % | $ 261 M | ||
|
e.l.f. Beauty
ELF
|
1.1 | $ 112.94 | -1.14 % | $ 6.58 B | ||
|
Edgewell Personal Care Company
EPC
|
0.68 | $ 28.0 | -0.21 % | $ 1.33 B | ||
|
Unilever PLC
UL
|
14.21 | $ 65.64 | -0.9 % | $ 143 B | ||
|
Inter Parfums
IPAR
|
13.12 | $ 115.32 | 0.09 % | $ 3.7 B | ||
|
LifeVantage Corporation
LFVN
|
8.17 | $ 5.72 | -2.39 % | $ 71.7 M | ||
|
Mannatech, Incorporated
MTEX
|
-50.68 | $ 8.64 | 2.49 % | $ 16.4 M | ||
|
Nature's Sunshine Products
NATR
|
7.48 | $ 12.3 | 1.19 % | $ 221 M | ||
|
Nu Skin Enterprises
NUS
|
11.4 | $ 4.69 | -2.09 % | $ 231 M | ||
|
Newell Brands
NWL
|
-2.66 | $ 5.4 | 0.75 % | $ 2.26 B | ||
|
The Procter & Gamble Company
PG
|
12.68 | $ 159.94 | -0.67 % | $ 373 B |